About Me

WEDrs 4436

Dr Cameron Schauer

Consultant Gastroenterologist and Physician

I am a consultant gastroenterologist (specialist in the diagnosis and treatment of diseases affecting the gastrointestinal tract which includes organs from mouth to the anus). In addition I work as a general physician at North Shore and Waitakere Hospital, and in private at Waitemata Endoscopy and Waitemata Specialists. I am a clinical senior lecturer at the University of Auckland. 

Medicine

I grew up in Whangerei, attended boarding school in Auckland and studied medicine at Auckland University.

I started work as a doctor in 2012, and have practiced in Whangarei, Auckland City Hospital including at the New Zealand Liver Transplant Unit, Middlemore and Tauranga Hospitals, and am currently also working in North Shore and Waitakere Hospital.

Patient goals

I believe in a compassionate, holistic and comprehensive assessment of my patients and strive for excellence in providing the very best healthcare. I hold myself to a very high standard and keep up to date with the latest in medical innovation, endoscopic techniques and research. My goal is for patients to feel comfortable to share their concerns, then work together to safely and efficiently diagnose and treat these problems with them.

I perform, partake and publish research articles in peer reviewed journals and present at international conferences on a wide range of medical topics, including gastroenterology and endoscopy (see list below).

Full list of publications and citations

In 2019 I was the first New Zealander to be awarded a research fellowship role in Tokyo, Japan, where under the tutelage of Dr. Ken Ohata, a leading world expert and his team, I learnt new endoscopic techniques to improve patient comfort performing gastroscopy and colonoscopy, as well as enhanced techniques to pick up subtle abnormalities and methods to accurately diagnose these and then successfully remove these endoscopically (through the camera).

IMG 1868 v2

Although I enjoy all aspects of gastroenterology I am particularly interested in gastroscopy and colonoscopy for the early detection of cancer in the stomach and colon. With techniques learnt in Japan, very small and subtle changes on the walls of these organs can be detected, and if diagnosed early, pre-cancers or cancers may be safely and completely removed without the need for invasive surgery or chemotherapy.

IMG 1482

Outside of work, I enjoy fishing, rugby (both league and union!) and spend lots of time at the zoo with my family!

PUBLICATIONS

2022:

  • Schauer C, Pandey R, Minato Y, Muramoto T, Ohata K, Khan I. Endoscopic submucosal dissection: the first reported experience from a New Zealand centre. N Z Med J. Vol 135 No 1550: 25 February 2022

2021:

  • Schauer C, Avery V, Seleq S, Garg P, Wang MT, Chieng M, Rowan C, Sekra A, Lane M, Walmsley R. A comparison of intravenous methylprednisolone and hydrocortisone for the treatment of acute inflammatory bowel disease. J Gastroenterol Hepatol. 2021 May 3. doi: 10.1111/jgh.15535. Epub ahead of print. PMID: 33939853.
  • Schauer C. Quality Of Life After Oesophageal Stenting In Patients With Palliative Oesophageal Cancer. Accepted in Print; N Z Med J. 2021 July
  • Schauer C. Art in Endoscopy: "The smiling diverticulum". Endoscopy. 2021 Mar;53(3):217. doi: 10.1055/a-1354-7106. Epub 2021 Feb 25. PMID: 33631820.
  • Schauer C, Wijesinghe U, Wang MT, Selvaratnam S, Lal D. Improving efficiency of current diagnostic pathways for investigation of colorectal cancer in symptomatic patients. N Z Med J. 2021 Feb 19;134(1530):123-125. PMID: 33651784.

2020

  • Schauer C, Plant A, Vandal AC, Claydon A. Outcomes Of Patients with Delayed Surveillance Colonoscopy. Internal Medicine Journal, 06 December 2020.
  • Schauer C, Mules T, Rijnsoever MV, Gane E. Increasing burden of advanced hepatocellular carcinoma in New Zealand-the need for better surveillance. N Z Med J. 2020 May 22;133(1515):25-34.
  • Schauer C, Koo YE, McBride S, Patel A. Hypothyroidism causing bilateral lower-limb compartment syndrome. N Z Med J. 2020 Mar 13;133(1511):86-89

2019

  • Panesar D, Schauer C, Raj A, Wilkins J, Wagener J. Acute Oesophageal Necrosis Following Septic Cellulitis. ANZ J Surg. 2019 Nov 12.
  • Braatvedt G, Kwan A, Dransfield W, McNamara C, Schauer C, Miller S, Khanolkar M. Differing protocols of managing adult diabetic ketoacidosis outside of the intensive care unit make no difference to the rate of resolution of hyperglycaemia and acidosis. NZ Med J. 2019 Oct; Vol 132 No 1504.
  • Schauer C, van Rijnsoever M, Gane E. Surveillance factors change outcomes in patients with hepatocellular carcinoma due to chronic hepatitis C virus infection in New Zealand. J Viral Hepat. 2019 Dec;26(12):1372-1376.
  • Schauer C, Chong L, Hendry K, Kozman MA, Rajaratnam S, Walmsley R. Perforated cytomegalovirus pseudotumour. ANZ J Surg. 2019 Mar 12.
  • Schauer C, Floyd T, Chin J, Vandal A, Lampen-Smith A. Video or verbal? A randomised trial of the informed consent process prior to endoscopy. N Z Med J. 2019 Feb 1;132(1489):57-68.

Screen Shot 2021 01 10 at 11.20.23

2018

  • Sekra A, Schauer C, Mills L, Vandal A, Rose T, Lal D, Ogra R. Chromoendoscopy versus standard colonoscopy for detection of nonpolypoid dysplasia in patients with inflammatory bowel disease. N Z Med J. 2018 Jul 13;131(1478):32-38.

 2017

  • Schauer C, Cunliffe R. Marginal Zone Lymphoma of the Entire Gastrointestinal Tract. Am J Gastroenterol. 2018 Jan;113(1):149-150.
  • Schauer C, Diprose W, Verster F. Clinical assessment of central venous pressure: time for an update? Intern Med J. 2017 Mar;47(3):344-345.
  • Diprose W, Verster F, Schauer C. Re-examining physical findings with point-of-care ultrasound: a narrative review. N Z Med J. 2017 Jan 27;130(1449):46-51

2016

  • Schauer C, Buist N, Ekart J, Sherif M. A review of adherence to guidelines for the use of Computed Tomography Pulmonary Angiography (CTPA) for the diagnosis of Pulmonary Embolism. EC Pulmonology and Respiratory Medicine, 2.5 (2016): 172-180.                     

2015

  • Schauer C, Shand J, Reynolds T. The Fentanyl Patch Boil-Up - A Novel Method of Opioid Abuse. Basic Clin Pharmacol Toxicol. 2015 Nov;117(5):358-9
  • Sherif MM, Hall R, Schauer C. Azygos vein thrombosis secondary to a peripherally inserted central catheter (PICC). J Vasc Access. 2015 Jul 20;16(4):e82-3.
  • Sherif MM, Schauer C. Multifocal Cutaneous and Osseous Tuberculosis. Int J Infect Dis. 2015 Aug;37:11-3.
  • Mpe M, Schauer C. Splenosis Mimicking Cancer. N Engl J Med. 2016 May 19;374(20):1965
  • Schauer C, Prendergast CM, Mpe MJ. A scary chest X-ray. Emerg Med J. 2016 Apr;33(4):259.
  • Shand J, Bradley K, Schauer C. Idiopathic Pulmonary Vein Thrombosis in a Patient with Chronic Obstructive Pulmonary Disease. Eurasian J Pulmonol 2016; 18: 55-7
  • Buist N, Schauer C. Fever and elevated CRP-related to clozapine dose. Aust N Z J Psychiatry. 2016 Feb;50(2):182-3
  • Schauer C, Kelly T, Sherif M. Six-Minute Walk Testing-are we following the established guidelines?        Online Journal of Clinical Audits. 2015, Vol 7, No 3.
  • Schauer C, Hammer D. Quantifying patient bacterial exposure risk from reusable phlebotomy tourniquets in a New Zealand, secondary level hospital. J Infect Prev. 2015 Nov;16(6):262-265.

2012

  • Schauer C. An incidental case of profound hypothyroidism-important implications on the cardiovascular system. NZ Med Stud J. 2012 Jul;15: 14-16                      

2011

  • Dalbeth N, Schauer C, MacDonald P, et al Methods of tophus assessment in clinical trials of chronic gout: a systematic literature review and pictorial reference guide Annals of the Rheumatic Diseases 2011;70:597-604.

 

PRESENTATIONS:                                        

2020

  • Presentation: Speaker – Endoscopy experience in Japan. NZ Gastroenterology Society Conference, Auckland, New Zealand. November 2020.

2019

  • Presentation: Author. Colorectal Cancer But Not As You Know It: a Prospective Case Control Study Of Risk Factors, Symptoms and Signs. NZ Gastroenterology Society Conference, Wellington, New Zealand. November 2019.
  • Presentation: Author. Timing Of Colonoscopy: It Ain’t Easy! NZ Gastroenterology Society Conference, Wellington, New Zealand. November 2019.
  • Presentation: Author. Sneaking up from behind! Colorectal Cancer In Those Less Than The Screening Age. NZ Gastroenterology Society Conference, Wellington, New Zealand. November 2019.
  • Poster: Author. Outcomes Of patients with Delayed Surveillance Colonoscopies: A Large Cohort Study in Tauranga, New Zealand. Digestive Disease Week, San Diego, USA. May 2019.

2018

  • Presentation, Speaker: Janssen No Honorarium Speaker on Therapeutic Drug Monitoring for anti-TNFs and thiopurines in New Zealand. Auckland, New Zealand. November 2018.
  • Presentation, Speaker : Video or verbal? A randomised trial of the informed consent process prior to endoscopy. NZ Gastroenterology Society Conference, Dunedin, New Zealand. November 2018. Winner of New Zealand Gastroenterology Society ASM Young Investigator of the Year
  • Presentation, Speaker: Surveillance factors change outcomes in patients with hepatocellular carcinoma due to chronic hepatitis C virus infection in New Zealand. NZ Gastroenterology Society Conference, Dunedin, New Zealand. November 2018.
  • Poster, Author. Outcomes Of patients with Delayed Surveillance Colonoscopies: A Large Cohort Study in Tauranga, New Zealand. Winner of Poster Prize, NZ Gastroenterology Society Conference, Dunedin, New Zealand. November 2018.
  • Poster, Author: Pan-Depressed Disaccharidase Levels As a Rare Cause for Unexplained Gastrointestinal Symptoms. NZ Gastroenterology Society Conference, Dunedin, New Zealand. November 2018.
  • Poster, Author: High Rates Of Disaccharidase Enzyme Deficiency In Waitemata, Auckland. NZ Gastroenterology Society Conference, Dunedin, New Zealand. November 2018.
  • Poster, Author. A successful novel algorithm to manage undifferentiated chronic diarrhoea with empirical therapy. NZ Gastroenterology Society Conference, Dunedin, New Zealand. November 2018.
  • Poster, Author. Surveillance Factors In New Zealanders with chronic hepatitis B and C presenting with incurable hepatocellular carcinoma. NZ Gastroenterology Society Conference, Dunedin, New Zealand. November 2018.

2017

  • Poster: The First Case Series of the FDA approved Orbera Intragastric Balloon for Weight Loss in New Zealand. NZ Gastroenterology Society Conference, Auckland, New Zealand. November 2017.
  • Presentation, Speaker: Hepatitis Delta Infection. Hepatitis Update 2017, Auckland, New Zealand. August 2017.

2016

  • Presentation, Author: Improving Pulmonary Embolism Diagnosis: When Will We Learn? RACP Congress 2016, Adelaide, Australia. May 2016. Best Poster Prize in Adult Medicine.

 2014

  • Poster, Author: Comparison of retropubic versus perineal approaches for radical prostatectomy. Urological Society of Australia and New Zealand (USANZ) Conference. Brisbane, Australia, March 2014. Louis Barnett Prize for best presentation.
  • Poster, Author : Quantifying patient bacterial exposure risk from re-useable phlebotomy tourniquets. XIVth International Congress of Bacteriology and Applied Microbiology, International Union of Microbiological Societies (IUMS) Congresses. Montreal, Canada. August 2014.

2013

  • Presentation, Author: Long term outcomes of Prostate Cancer in Northland. NZ Urology Section Conference, Bay Of Islands, Northland. November 2013.         

OTHER:                      

  • 14 July 2020: New Zealand Gastroenterology Society Representative for the Asian-Pacific Society For Digestive Endoscopy
  • 24 January 2020: Admission to Fellowship of The Royal Australasian College of Physicians (FRACP)
  • August 2019:Japanese Society of Gastroenterology (JSGE) Research Fellowship Program Award: 4-month interventional endoscopy scholarship to work in Japanese Hospital.

Dec 2018-August 2019

Sub-investigator:

  • Hepatitis B cure trials - Three phase 1b trials.
  • Obeticholic Acid in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis (REVERSE study) - Phase 3
  • Randomized Global Phase 3 Study to Evaluate the Impact on NASH with Fibrosis of Obeticholic Acid Treatment (REGENERATE study) - Phase 3
  • Risankizumab M15-991 study for refractory Crohn’s disease